is semaglutide hard on your kidneys and Kidney Health: What Patients Need to Know There have been reports of

Both Semaglutide and Tirzepatide are effective for medically supervised weight loss, but they differ in mechanism, average outcomes, and side-effect patterns

Consistent with this concept, up to 30% of individuals with PsO eventually develop PsA, a chronic inflammatory arthropathy affecting peripheral joints, entheses, and the axial skeleton ( Early PsA may display nonspecific musculoskeletal symptoms, such as inflammatory arthralgia or morning stiffness, even in the absence of overt synovitis or radiographic erosions ( At the pathogenic level, PsO and PsA share core inflammatory mechanisms driven by dysregulation of the IL17/IL23 and Tumour Necrosis Factor (TNF)- cytokine axes ( These immune pathways are closely intertwined with metabolic abnormalities, particularly obesity and adipose tissue dysfunction

They belong to the same class of drugs, have similar mechanisms of action, and are self-administered as subcutaneous injections

Stacks discussed are for experimental design purposes only , not for safety or efficacy guidance

Sheetz MJ, King GL